PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares

Delisted

PHXM was delisted on the 8th of March, 2024.

9 hedge funds and large institutions have $9.94M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
1
Closed
5
Calls
$1.01M
Puts
Net Calls
+$1.01M
Net Calls Change
+$1.01M
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$6.43M 2,737,572 +2,737,572 New
BI
2
BVF Inc
California
$3.1M 1,314,656
Citadel Advisors
3
Citadel Advisors
Florida
$173K 73,325 +58,760 +403%
Jane Street
4
Jane Street
New York
$110K 45,639 +45,639 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$49K 20,711 -4,863 -19%
CS
6
Credit Suisse
Switzerland
$40K 16,900 +16,900 New
Group One Trading
7
Group One Trading
Illinois
$25K 10,615 +8,615 +431%
UBS Group
8
UBS Group
Switzerland
$8K 3,583 +3,583 New
TRCT
9
Tower Research Capital (TRC)
New York
$1K 321 +22 +7%
NMC
10
NEA Management Company
Maryland
-625,000 Closed
CC
11
Cannell & Co
New York
-26,000 Closed
ACM
12
ACT Capital Management
Pennsylvania
-2,000 Closed
HI
13
Harbour Investments
Wisconsin
-1,000 Closed
Morgan Stanley
14
Morgan Stanley
New York
-296 Closed
CFGS
15
Concourse Financial Group Securities
Alabama